Hong Kong (HSI) Publishing Industry Analysis

Industry Valuation and Performance

Has the Hong Kong Publishing Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Wed, 26 Aug 2026	HK$39.3b	HK$26.6b	-HK$281,859,432.35	22.4x	-139.3x	1.5x
Fri, 24 Jul 2026	HK$37.4b	HK$26.0b	HK$461.1m	24.5x	81.1x	1.4x
Sun, 21 Jun 2026	HK$38.5b	HK$26.1b	HK$453.2m	26.4x	85x	1.5x
Tue, 19 May 2026	HK$46.0b	HK$26.0b	HK$463.3m	15.1x	99.2x	1.8x
Thu, 16 Apr 2026	HK$48.3b	HK$25.9b	HK$464.4m	15.7x	103.9x	1.9x
Sat, 14 Mar 2026	HK$49.1b	HK$24.8b	HK$1.8b	25.1x	27.6x	2x
Mon, 09 Feb 2026	HK$55.0b	HK$24.6b	HK$1.8b	26x	31.3x	2.2x
Wed, 07 Jan 2026	HK$54.4b	HK$24.4b	HK$1.7b	26x	31.3x	2.2x
Fri, 05 Dec 2025	HK$55.5b	HK$24.1b	HK$1.7b	27.6x	32.4x	2.3x
Sun, 02 Nov 2025	HK$61.9b	HK$24.0b	HK$1.8b	16x	35.3x	2.6x
Tue, 30 Sep 2025	HK$59.8b	HK$24.4b	HK$1.8b	16.2x	32.9x	2.5x
Thu, 28 Aug 2025	HK$63.4b	HK$24.6b	HK$1.7b	16.2x	37.3x	2.6x
Sat, 26 Jul 2025	HK$52.0b	HK$25.8b	HK$1.3b	12.5x	38.7x	2x
Mon, 23 Jun 2025	HK$49.1b	HK$25.8b	HK$1.4b	12.1x	36.4x	1.9x
Wed, 21 May 2025	HK$45.7b	HK$25.7b	HK$1.4b	7.9x	32.5x	1.8x
Fri, 18 Apr 2025	HK$45.4b	HK$25.3b	HK$1.3b	8.2x	34.4x	1.8x
Sun, 16 Mar 2025	HK$45.7b	HK$25.3b	HK$2.6b	10.4x	17.9x	1.8x
Tue, 11 Feb 2025	HK$48.6b	HK$25.1b	HK$2.5b	10.2x	19.1x	1.9x
Thu, 09 Jan 2025	HK$44.6b	HK$25.0b	HK$2.5b	9.9x	17.6x	1.8x
Sat, 07 Dec 2024	HK$48.2b	HK$25.2b	HK$2.6b	10.1x	18.9x	1.9x
Mon, 04 Nov 2024	HK$46.7b	HK$25.7b	HK$2.6b	9.8x	17.8x	1.8x
Wed, 02 Oct 2024	HK$53.4b	HK$26.0b	HK$2.7b	9.8x	20.1x	2.1x
Fri, 30 Aug 2024	HK$43.8b	HK$25.7b	HK$2.6b	8.9x	16.7x	1.7x
Sun, 28 Jul 2024	HK$43.5b	HK$24.1b	HK$2.5b	10x	17.5x	1.8x
Tue, 25 Jun 2024	HK$45.0b	HK$24.2b	HK$2.4b	13.6x	18.8x	1.9x
Thu, 23 May 2024	HK$48.2b	HK$24.2b	HK$2.5b	8.1x	19.5x	2x
Sat, 20 Apr 2024	HK$43.7b	HK$24.1b	HK$2.5b	7.1x	17.7x	1.8x
Mon, 18 Mar 2024	HK$45.4b	HK$23.7b	HK$2.4b	8.1x	19.1x	1.9x
Wed, 14 Feb 2024	HK$37.2b	HK$23.7b	HK$2.4b	8.5x	15.6x	1.6x
Fri, 12 Jan 2024	HK$43.7b	HK$23.8b	HK$2.4b	8.9x	18.2x	1.8x
Sun, 10 Dec 2023	HK$45.9b	HK$23.8b	HK$2.4b	9.7x	19.1x	1.9x
Tue, 07 Nov 2023	HK$47.9b	HK$23.6b	HK$2.5b	11.7x	19x	2x
Thu, 05 Oct 2023	HK$46.7b	HK$23.3b	HK$2.4b	12x	19.7x	2x
Sat, 02 Sep 2023	HK$35.4b	HK$11.1b	HK$836.1m	16.3x	42.4x	3.2x

Current Industry PE

Investors are pessimistic on the Hong Kong Publishing industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.5x.

Past Earnings Growth

Total earnings for the Publishing industry have declined over the last three years, with the industry now making a loss overall.
Meanwhile revenues have grown 34% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Hong Kong Publishing compare with similar industries?


HK Market	1.49%
Telecom	-0.57%
Media	-0.035%
Publishing	-0.95%
Advertising	0.42%
Cable and Satellite	0%	0
Broadcasting	-2.67%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

	Company	Last Price	7D	1Y	Valuation
	343 Culturecom Holdings	HK$0.11	0.9% +HK$1.7m	-33.1%	PS11.1x

Company

Last Price

Valuation

343 Culturecom Holdings

HK$0.11

0.9%
+HK$1.7m

-33.1%

PS11.1x

Culturecom Holdings Limited Appoints Sheng Haiyuan and as Independent Non-Executive Director and as Member of the Audit Committee and the Nomination Committee, Effective 24 August 2026

Culturecom Holdings Limited announced that Ms. Sheng Haiyuan was appointed as an independent non-executive Director and a member of each of the audit committee of the Company and the nomination committee of the Company, all with effect from August 24, 2026. Ms. Sheng Haiyuan, aged 40, has over 15 years of end-to-end working experience in the biomedical industry covering three major areas: research and development, industrialisation management and capital market operations. She holds a Master’s degree in Microbiology from Anhui Agricultural University and has completed the EMBA programme at Jinan University. She previously worked as a research assistant at the University of Science and Technology of China. She is familiar with biochemistry and biomedical R&D workflows, and well-versed in the full-cycle development pathway of pharmaceutical products from R&D through to commercial launch. She is currently director of the chairman’s office at Hefei Tianhui Biotechnology Co. Ltd. and general manager of Haimaitongheng (Hong Kong) Co. Ltd. Since 2011, she has held positions at Hefei Tianmai Biotechnology Development Co. Ltd. and Hefei Tianhui Biotechnology Co. Ltd. successively. Her professional experience spans the full spectrum of technology transfer and local implementation, production-line construction, process development and product registration for multiple biomedical products. She also has extensive experience in project financing, corporate listing exercises, commercial negotiations, business-development (BD) transactions and investor-relations management. She is committed to empowering the governance of listed companies with industrial insights, and driving the sustainable realisation of corporate strategic value within a compliance-oriented framework. Ms. Sheng has entered into an appointment letter with the Company for a term of one year commencing from August 24, 2026. Each of the Company and Ms. Sheng is entitled to terminate the appointment letter at any time by giving the other party one month’s notice in writing. Her appointment is subject to retirement and re-election in the annual general meetings of the Company in accordance with the Bye-laws of the Company. Following the appointment of Ms. Sheng, the Board comprised five Directors, of which two were executive Directors and three were independent non-executive Directors. The Company complied with the requirements under Rules 3.10(1), 3.21 and 13.92 of the Listing Rules and B.3.5 of the corporate governance code set out in Appendix C1 of the Listing Rules.

Hong Kong (HSI) Publishing Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

Culturecom Holdings Limited Appoints Sheng Haiyuan and as Independent Non-Executive Director and as Member of the Audit Committee and the Nomination Committee, Effective 24 August 2026

772: IP And AI Content Expansion Will Drive Future Upside Potential

Upcoming dividend of HK$0.01 per share

Sing Tao News Corporation Limited to Report First Half, 2026 Results on Aug 28, 2026

Media Chinese International Limited to Report Q1, 2027 Results on Aug 26, 2026

Jiufang Digital Technology Holdings Limited to Report First Half, 2026 Results on Aug 24, 2026

Sino Splendid Holdings Limited to Report First Half, 2026 Results on Aug 31, 2026

Upcoming dividend of HK$0.04 per share

Xinhua Winshare Publishing and Media Co., Ltd. to Report First Half, 2026 Results on Aug 27, 2026